Sharklet Technologies Revenue and Competitors

Denver, CO USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Sharklet Technologies's estimated annual revenue is currently $2.5M per year.(i)
  • Sharklet Technologies's estimated revenue per employee is $358,571

Employee Data

  • Sharklet Technologies has 7 Employees.(i)
  • Sharklet Technologies grew their employee count by -12% last year.

Sharklet Technologies's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M240%N/AN/A
#2
$5.3M16-6%N/AN/A
#3
$2.5M7-12%N/AN/A
#4
$11.5M4929%N/AN/A
#5
$5.5M22-33%N/AN/A
#6
$10.8M389%N/AN/A
#7
$30.4M121-10%N/AN/A
#8
$61.5M2125%N/AN/A
#9
$3.3M110%N/AN/A
#10
$27.4M109N/AN/AN/A
Add Company

What Is Sharklet Technologies?

Sharklet is the world's first technology to inhibit bacterial growth through pattern alone. The Sharklet surface is comprised of millions of microscopic features arranged in a distinct diamond pattern. The structure of the pattern alone inhibits bacteria from attaching, colonizing and forming biofilms. Sharklet contains no toxic additives or chemicals, and uses no antibiotics or antimicrobials. Sharklet draws inspiration from the shape and pattern of the dermal denticles of sharkskin. Sharks are resistant to fouling organisms in the water including algae and barnacles. Originally discovered by Dr. Tony Brennan at the University of Florida, Sharklet has licensed the technology to develop medical devices and consumer applications.

keywords:N/A

N/A

Total Funding

7

Number of Employees

$2.5M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sharklet Technologies News

2022-04-17 - Coated Endotracheal Tube Market to Experience Significant ...

Innovative Surface Technologies N8 Medical, LLC Sharklet Technologies, Inc. ... Technological advancement in endotracheal tubes.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.9M7-22%N/A
#2
$0.9M7-30%N/A
#3
$1M7-36%N/A
#4
N/A70%N/A
#5
$3.5M7-82%N/A